Oct 01, 2018
Infinity Pharmaceuticals Earns $22 Million Payment From Verastem Oncology For FDA Approval Of COPIKTRA(TM) (duvelisib) And Updates 2018 Financial Guidance
Sep 26, 2018
Infinity To Present At Cantor Fitzgerald Global Healthcare Conference
Aug 28, 2018
Infinity To Present At Three Upcoming Investor Conferences In September
Aug 07, 2018
Infinity Pharmaceuticals Provides Company Update and Second Quarter 2018 Financial Results
Jul 31, 2018
Infinity Announces The Date Of Its Second Quarter 2018 Financial Results Conference Call And Webcast
Jun 26, 2018
Arcus Biosciences and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Lead Programs in Triple-Combination Studies
Jun 04, 2018
Infinity Reports IPI-549 Clinical and Translational Data from Ongoing Phase 1/1b Study at American Society of Clinical Oncology Annual Meeting
May 08, 2018
Infinity Announces Presentations On IPI-549 At Upcoming American Society of Clinical Oncology Annual Meeting
May 08, 2018
Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results
May 01, 2018
Infinity Announces The Date Of Its First Quarter 2018 Financial Results Conference Call And Webcast
Mar 26, 2018
Infinity to Present at Two Upcoming Conferences
Mar 21, 2018
Infinity To Present At BioCentury's 25th Annual Future Leaders In The Biotech Industry Conference
Mar 15, 2018
Infinity Pharmaceuticals Provides Company Update and Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 08, 2018
Infinity Announces the Date of Its Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast
Mar 08, 2018
Infinity Pharmaceuticals Announces Additions to Board of Directors and Clinical Leadership Team and Establishes Scientific Advisory Board
Feb 05, 2018
Infinity To Present At BIO CEO & Investor Conference
Jan 08, 2018
Infinity Provides Update on IPI-549 Phase 1/1b Study, 2018 Goals and Financial Guidance
Jan 05, 2018
Infinity To Present At 36th Annual J.P. Morgan Healthcare Conference
Nov 10, 2017
Infinity Pharmaceuticals Reports IPI-549 Clinical and Translational Data from Completed Monotherapy Dose-Escalation Component of Phase 1/1b Clinical Study in Patients with Advanced Solid Tumors at SITC Annual Meeting
Nov 07, 2017
Infinity Provides Company Update and Reports Third Quarter 2017 Financial Results